Anti-Ly6g + Ly6c antibody [RB6-8C5] (Ab25377)

Lymphocyte antigen 6G, Ly-6G, Ly-6G.1, Ly6g, Lymphocyte antigen 6C1, Ly-6C1, Ly6c1

反应种属:Mouse
抗原名称:Ly6g
应用:IHC, FCM

详细信息

免疫原The exact immunogen used to generate this antibody is proprietary information. Full Length Protein corresponding to Mouse Ly6c1. Database link P0CW02
宿主/亚型Rat / IgG2b
抗体类型Monoclonal
产品形式Liquid
储存缓冲液pH: 8.2 Constituents: 100% Borate buffered saline
储存条件运输条件: Blue Ice 推荐的短期储存条件: +4°C 推荐的长期储存条件: -20°C 储存信息: Avoid freeze / thaw cycle
无载体蛋白No

背景信息

Product Specifications Anti-Ly6g + Ly6c antibody [RB6-8C5] (ab25377) is a rat Monoclonal antibody and is validated for use in Flow Cyt, IHC-Fr, IHC-P in mouse samples. Anti-Ly6g + Ly6c antibody [RB6-8C5] (ab25377) specifically detects Ly6g +Ly6c (UniProt ID: P35461; Molecular weight: 9kDa) and is sold in a convenient trial size to enable initial testing (25 µg) and larger sizes for subsequent scaling up experiments (100 µg). Quality and Validation Abcam's high quality validation processes ensure Anti-Ly6g + Ly6c antibody [RB6-8C5] (ab25377) has high sensitivity and specificity. Anti-Ly6g + Ly6c antibody [RB6-8C5] (ab25377) has been cited over 193 times in peer reviewed journals and is trusted by the scientific community. Anti-Ly6g + Ly6c antibody [RB6-8C5] (ab25377) has 5 independent reviews from customers. Related Products Antibody clone RB6-8C5 is also available pre-conjugated to a variety of labels for your convenience - PE, FITC, APC, PE/Cy7®, Biotin, redFluor™ 710, violetFluor™ 450 ( ab24884, ab25024, ab25273, ab25514, ab25680, ab242065, ab253070 ). This product was changed from ascites to tissue culture supernatant on 2nd March 2020. Lot numbers higher than GR3218400 are from tissue culture supernatant. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team. REACH authorisation Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances. It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

文献引用 (223)

Inducible CD147 up-regulation boosts extended SARS-CoV-2 infection triggering severe COVID-19 independent of ACE2

诱导型 CD147 上调可延长 SARS-CoV-2 感染,并引发重症 COVID-19,且该过程独立于 ACE2。

Ke Wang #,Peng Lin #,Ruo Chen #,Qiang Huang #,Yizhen Zhao #,Lei Zhang,Yongxiang Zhao,Liping Zhong,Ke Xu,Linlin Bao,Youchun Wang,Chuan Qin,Guizhen Wu,Hai Zhang,Jiejie Geng,Zheng Zhang,Ding Wei,Xiaochun Chen,Hao Tang,Liu Yang,Xu Yang,Xiuxuan Sun,Rui Yao,Ye Zhao,Weijun Qin,Zhiwei Yang,Liang Chen,Huijie Bian,Zhi-Nan Chen,Ping Zhu

Living sensor display implanted on skin for long-term biomarker monitoring.

植入皮肤上的活体传感器显示器,用于长期生物标志物监测。

Sawayama Jun, Takeo Makoto, Takayama Yuki, Takase Miki, Aoyagi Hoshimi, Takimoto Aki, Mizutani Saki, Onuki Maiko, Ikeo Satoshi, Nagata Shogo, Ogawa Miho, Yano Koji, Tsuji Takashi, Takeuchi Shoji, Fujita Hiroyuki

Hyodeoxycholic acid attenuates atherosclerosis by antagonizing FXR and modulating the PD-1/mTORC1 signaling axis.

脱氧胆酸通过拮抗 FXR 和调节 PD-1/mTORC1 信号轴来减轻动脉粥样硬化。

Yang Feng, Huang Wenqiong, Meng Zongzhen, Liu Meijun, Lyu Aiping, Mauro Claudio, Cheung Kenneth C P

Neutrophil methylmalonic acid promotes microthrombus formation and adverse cardiac remodeling post-myocardial infarction through activating IL-6 signaling pathway-mediated NETosis.

中性粒细胞甲基丙二酸通过激活IL-6信号通路介导的NETosis,促进心肌梗死后微血栓形成和不良心脏重塑。

Liu Yige, Wang Jiaxin, Cai Hengxuan, Wang Zeng, Lu Rongzhe, Liu Xiaoxuan, Wang Mingyang, Wang Wei, Guo Junchen, Ma Guanpeng, Zhang Zhenming, Wu Pengyan, She Qin, Wu Xiaoming, Xiu Lili, Yu Bo, Gao Xueqin, Li Zhaoying, Wang Shanjie, Fang Shaohong

IL-10R inhibition induces neutrophil tumoricidal activity.

IL-10R抑制可诱导中性粒细胞的杀瘤活性。

Khalil Danny N, Gomez Ricardo, Regev Amit, Samaan Fadi, Marouf Yacine, Budhu Sadna, Hirschhorn Daniel, Schulze Isabell, Lavery Jessica A, Ceglia Nicholas, Freeman Samuel S, Maltez Vivien I, Garcia Jaynia M, Suek Nathan, Weng Chien-Huan, Cabanski Christopher R, Monette Sebastien, Romin Yevgeniy, Li Yanyun, Chaligne Ronan, Yellin Michael J, Keler Tibor, Maurer Deena M, Flamar Anne-Laure, Morgado-Palacin Lucia, Mangarin Levi M, Harding James J, Park Wungki, Lyman Jaclyn P, Maddock Stephen, O'Hara Mark H, Abou-Alfa Ghassan K, Vonderheide Robert H, O'Reilly Eileen M, Germain Ronald N, Wolchok Jedd D, Merghoub Taha

Galectin-9(high) Neutrophils Exacerbate Radiation-Induced Frailty.

高半乳糖凝集素-9中性粒细胞加剧辐射引起的虚弱。

Cheng Zhuo, Ma Le, Chen Yan, Li Jialun, Dai Yali, Xie Wentao, Li Yingjie, Xu Tianlang, Hu Zhihe, Huang Weilin, Zhou Jingyuan, Wu Jie, Chen Long, Shi Chunmeng

Lymphatic Endothelial C-C Motif Chemokine Ligand 2 Enhances Lymphangiogenesis and Lymphatic Clearance of Macrophages Following Myocardial Infarction.

淋巴内皮 CC 基序趋化因子配体 2 增强心肌梗死后的淋巴管生成和巨噬细胞的淋巴清除。

Deng Shengqiong, Zhao Kang, Cai Zeen, Li Qinyu, Li Shan, Zhou Caixia, Duan Yunhao, Wu Jinjin, Zhang Lin, Luo Yu

Neuroimmune Activation in a Goat Model of Intervertebral Disc Degeneration.

神经免疫激活在山羊椎间盘退变模型中的作用。

Augustin Janai A, Burt Kevin G, Barrett Caitlin, Fainor Matthew, Orozco Brianna S, Schaer Thomas P, Smith Harvey E, Mauck Robert L, Gullbrand Sarah E

PLGA nanofibers carrying rhFGF1 for the effective treatment of skin wounds in diabetic mice.

PLGA纳米纤维携带rhFGF1,可有效治疗糖尿病小鼠的皮肤伤口。

Zhang Yujie, Wang Xianshi, Ye Shasha, Li Jiana, Wu Junyi, Bao Xiaoyan, Zhao Yeli

Resistance to anti-LAG-3 plus anti-PD-1 therapy in head and neck cancer is mediated by Sox9+ tumor cells interaction with Fpr1+ neutrophils.

头颈癌对 LAG-3 抗 PD-1 疗法的耐药性是由 Sox9+ 肿瘤细胞与 Fpr1+ 中性粒细胞相互作用介导的

Wang Xiaochen, Cheng Maosheng, Chen Shuang, Zhang Caihua, Ling Rongsong, Qiu Shuqing, Chen Ke, Zhou Bin, Li Qiuli, Lei Wenbin, Chen Demeng
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 23